Home | Welcome to Contract Pharma   
Last Updated Thursday, May 28 2015


Formex Names Scientific Advisor

Published August 14, 2014
Related Searches: Formulation Development formulation Manufacturing Dosage
John McCarty has been named scientific advisor at Formex LLC, and a science advisory board member. Mr. McCarty has more than 30 years of experience in drug product development in the pharmaceutical and biotechnology industries, with expertise in the development of all major dosage forms, and is an inventor on 17 patents. 
Mr. McCarty previously held several senior management positions in R&D at Key Pharmaceuticals, Schering–Plough, and Pharmavene (acquired by Shire) and also served as vice president of formulation development at Azo Pharma.
"John brings a wealth of knowledge and expertise in formulation development, operations, and manufacturing for both clinical and commercial products to Formex.  We are extremely pleased to work with John as our Senior Consultant and Member of our Scientific Advisory Board," said Dr. J. Blair West, chief scientific officer of Formex. "John is well prepared to contribute to Formex as we continue to grow and expand in our capabilities and market presence."

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On